Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PITO-001
- Development stage
- Preclinical
- Lead developer
- Aquavit Pharmaceuticals
- Administration
- Intradermal, Subcutaneous
01
Overview
PITO-001, also known as APOLLO, is a personalized injection treatment optimization platform developed by Aquavit Pharmaceuticals. It is designed as a technology for optimizing the delivery and efficacy of injectable treatments, particularly within the fields of dermatology and aesthetics. As a platform technology, it focuses on the precision and personalization of injection protocols rather than acting on a specific molecular target. The system is part of Aquavit's broader portfolio of drug delivery and medical device technologies aimed at improving patient outcomes through customized treatment parameters.
- Brand names
- APOLLO
- Other names
- Personalized Injection Treatment Optimizer
Beyond the preview
Go deeper on PITO-001.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PITO-001.